Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest abdominal aortic aneurysm Stories

2011-12-22 02:00:00

SANTA ROSA, Calif., Dec. 22, 2011 /PRNewswire/ -- TriVascular, Inc. of Santa Rosa, California, announced today the first Canadian patients treated with its Ovation(TM) Abdominal Stent Graft. The innovative, ultra low profile (14F OD) system is designed to expand the patient population suitable for endovascular aortic repair (EVAR) by addressing a wider range of diseased anatomy. Cherrie Abraham, MD, Vascular Surgery, McGill University, performed the first case in Canada at...

2011-11-11 06:50:52

(Ivanhoe Newswire) -- Medical scientists have for the first time identified a gene responsible for a fatal abdominal condition that afflicts tens of thousands of people across the world. An international team led by Matt Bown, a vascular surgeon from the University of Leicester, identified a single gene that is linked to the development of abdominal aortic aneurysms, AAAs. What is more, the team discovered that the gene, LRP1, was not linked to other cardiovascular diseases, suggesting...

2011-11-04 21:30:34

Discovery paves way for new methods to treat aneurysms Medical scientists have for the first time identified a gene responsible for a fatal abdominal condition that afflicts tens of thousands of people across the world. An international team led by Matt Bown, a vascular surgeon from the University of Leicester, identified a single gene that is linked to the development of abdominal aortic aneurysms (AAAs). What is more, the team discovered that the gene, LRP1, was not linked to other...

2011-11-02 12:22:00

SILVER SPRING, Md., Nov. 2, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration has approved a stent graft system that provides patients with small arteries the option of less invasive surgery to repair their potentially life-threatening abdominal aortic aneurysm. (Logo: <font size="2" face="Arial">http://photos.prnewswire.com/prnh/20090824/FDALOGO</font>) An abdominal aortic aneurysm is a bulge in the part of the aorta that runs through the...

2011-10-25 06:00:00

MIAMI BEACH, Fla., Oct. 25, 2011 /PRNewswire/ -- Endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) take center stage at the upcoming 24th Annual International Symposium on Endovascular Therapy (ISET), which brings together physicians, scientists, researchers and industry professionals working in the multidisciplinary field of peripheral and cardiac interventional medicine. The meeting will be held January 15-19, 2012 at the Fontainebleau Miami Beach, with...

2011-08-17 08:15:00

IRVINE, Calif., Aug. 17, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that Judge Tanya Walton Pratt of the United States District Court for the Southern District of Indiana in Indianapolis has issued a Markman ruling in the ongoing patent infringement lawsuit filed against the Company by Cook Medical. In a Markman ruling, the court determines the meaning of disputed patent claim terms at...

2011-08-08 08:00:00

IRVINE, Calif., Aug. 8, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that the first U.S. commercial implant of the Company's AFX(TM) Endovascular AAA System was performed at Edward Hines, Jr. VA Hospital in Chicago, IL. The procedure was performed by Ross Milner, M.D., F.A.C.S., Associate Professor and Chief of Vascular Surgery & Endovascular Therapy at Loyola University in Chicago,...

2011-08-03 15:15:00

IRVINE, Calif., Aug. 3, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at two upcoming investor conferences. The first presentation will be at the 31st Annual Canaccord Genuity Growth Conference in Boston, MA. Event: 31st Annual Canaccord Genuity Growth Conference Date: Thursday, August...

2011-07-25 13:19:00

SANTA ROSA, Calif., July 25, 2011 /PRNewswire/ -- TriVascular, Inc. today announced the successful treatment of the first 5 patients in the OVATION study, a multicenter, prospective, European Post Market Registry. The patients were treated in Germany at Stadtisches Klinikum, Karlsruhe by Prof. Martin Storck and at Universitares Herz und Gefasszentrum, Hamburg by Dr. Hans Krankenberg. "It is an honor to be the first site to enroll a patient in TriVascular's OVATION study. Ovation's...

2011-07-18 07:30:00

IRVINE, Calif., and BURLINGTON, Mass., July 18, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, and LeMaitre Vascular, Inc. (Nasdaq: LMAT), provider of peripheral vascular devices and implants, announced today that the companies have entered into an early termination agreement for LeMaitre's distribution rights of Endologix's aortic endovascular products in Europe. Under the terms of the agreement,...